iGenomeDx
Clinical molecular diagnostics laboratory (San Antonio, TX) providing DNA-based infectious disease testing, pharmacogenomics, drug monitoring (toxicology) and related clinical reporting services. Operates a CLIA- and CAP-certified laboratory, offers multiple sample types (swab, urine, oral), in-house kit preparation, secure online result delivery and clinician consultation.
Industries
Nr. of Employees
small (1-50)
iGenomeDx
2040 Babcock Road Ste 201, San Antonio, TX 78229
Products
DNA-Based Infectious Disease Testing
A diagnostic service using DNA fragment primers to detect bacterial, viral, and fungal pathogens from patient samples for accurate infectious disease identification.
Pharmacogenomics Testing
Genetic testing service analyzing patient DNA to predict individual responses to medications, guiding personalized drug therapy and dosage.
COVID-19 Testing
PCR-based nucleic acid amplification test using nasopharyngeal swabs to detect SARS-CoV-2 infection.
Molecular Diagnostic Test Panels for Infectious Diseases
Comprehensive panels testing for multiple pathogens causing respiratory, urinary tract, sexually transmitted, gastrointestinal, wound, and nail infections.
Medication Management Testing via Saliva and Urine
Testing service using saliva and urine samples to support medication management and monitoring.
DNA-Based Infectious Disease Testing
A diagnostic service using DNA fragment primers to detect bacterial, viral, and fungal pathogens from patient samples for accurate infectious disease identification.
Pharmacogenomics Testing
Genetic testing service analyzing patient DNA to predict individual responses to medications, guiding personalized drug therapy and dosage.
COVID-19 Testing
PCR-based nucleic acid amplification test using nasopharyngeal swabs to detect SARS-CoV-2 infection.
Molecular Diagnostic Test Panels for Infectious Diseases
Comprehensive panels testing for multiple pathogens causing respiratory, urinary tract, sexually transmitted, gastrointestinal, wound, and nail infections.
Medication Management Testing via Saliva and Urine
Testing service using saliva and urine samples to support medication management and monitoring.
Services
Genetic testing panels and reports that guide medication selection and dosing across therapeutic classes using non-invasive cheek swab collection.
DNA-/RNA-based panels for respiratory (including SARS‑CoV‑2), UTI, STI, gastroenteritis, wound and nail/fungal infections with pathogen and resistance marker detection.
Urine and oral fluid drug screening with immunoassay followed by LC‑MS confirmation and quantification for clinical and forensic purposes.
Distribution of specimen collection kits (infectious disease, pharmacogenomics, toxicology) to provider facilities with online ordering.
On-demand mobile specimen collection for telehealth and clinic patients to reduce barriers to testing and ensure professional specimen handling.
Genetic testing panels and reports that guide medication selection and dosing across therapeutic classes using non-invasive cheek swab collection.
DNA-/RNA-based panels for respiratory (including SARS‑CoV‑2), UTI, STI, gastroenteritis, wound and nail/fungal infections with pathogen and resistance marker detection.
Urine and oral fluid drug screening with immunoassay followed by LC‑MS confirmation and quantification for clinical and forensic purposes.
Distribution of specimen collection kits (infectious disease, pharmacogenomics, toxicology) to provider facilities with online ordering.
On-demand mobile specimen collection for telehealth and clinic patients to reduce barriers to testing and ensure professional specimen handling.
Expertise Areas
- Molecular diagnostics
- Infectious disease testing (molecular)
- Pharmacogenomics and medication guidance
- Clinical toxicology and drug monitoring
Key Technologies
- Polymerase chain reaction (PCR/RT-PCR)
- Nucleic acid amplification
- Next-generation sequencing (NGS)
- Liquid chromatography–mass spectrometry (LC‑MS)
News & Updates
Interview describing company founding, services, RT‑PCR COVID‑19 validation, EUA submission and mobile phlebotomy implementation (June 2020).
Article on utilization of urine drug tests to manage patients, authored by laboratory leadership.
Awarded Minority-Owned Small Business of the Year by the U.S. Small Business Administration San Antonio District Office (SBA).
Announcement that the laboratory is STARC certified (publication posted September 7, 2023).
Interview describing company founding, services, RT‑PCR COVID‑19 validation, EUA submission and mobile phlebotomy implementation (June 2020).
Article on utilization of urine drug tests to manage patients, authored by laboratory leadership.
Awarded Minority-Owned Small Business of the Year by the U.S. Small Business Administration San Antonio District Office (SBA).
Announcement that the laboratory is STARC certified (publication posted September 7, 2023).